Voriconazole Tablets, VORICONAZOLE

【Generic Name】
Voriconazole Tablets 
【Indications】 
This product is a broad-spectrum triazole antifungal agent indicated for the treatment of the following fungal infections in adults and children aged 2 years and older: 
(1) Invasive aspergillosis. 
(2) Candidemia in patients without neutropenia. 
(3) Severe invasive infections caused by fluconazole-resistant Candida species (including Candida krusei). 
(4) Severe infections caused by the genera Footloose and Fusarium. 
This product is primarily indicated for the treatment of patients with progressive, potentially life-threatening fungal infections. 
Prevention of invasive fungal infections in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). 
【Specifications】
(1) 50 mg (2) 0.2 g 
50 mg specification: 【National Drug Approval No. H202439320】 0.2 g specification: 【National Drug Approval No. H20243933】 
For more information, please refer to the instruction manual.